Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- Author
- SCIRICA, Benjamin M1 ; BHATT, Deepak L1 2 ; CAVENDER, Matthew A1 ; UDELL, Jacob A1 ; DESAI, Nihar R1 ; MOSENZON, Ofri8 ; MCGUIRE, Darren K5 ; RAY, Kausik K9 ; LEITER, Lawrence A10 ; RAZ, Itamar8 ; BRAUNWALD, Eugene1 ; STEG, P. Gabriel3 ; DAVIDSON, Jaime4 ; HIRSHBERG, Boaz6 ; OHMAN, Peter6 ; FREDERICH, Robert7 ; WIVIOTT, Stephen D1 ; HOFFMAN, Elaine B1
[1] TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School, United States
[2] VA Boston Healthcare System, Boston, United States
[3] INSERM Unité 698, Université Paris-Diderot, and Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Assistance Publique―Hôpitaux de Paris, Paris, France
[4] Divisions of Endocrinology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, United States
[5] Cardiovascular Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, United States
[6] AstraZeneca Research and Development, Wilmington, DE, United States
[7] Bristol-Myers Squibb, Princeton, NJ, United States
[8] Diabetes Unit, Department of Internal Medicine, Hadassah University Hospital, Jerusalem, Israel
[9] Cardiovascular Sciences Research Centre, St. George's University of London, London, United Kingdom
[10] Division of Endocrinology and Metabolism, Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto, Toronto, Canada
SAVOR-TIM I 53 Steering Committee and Investigators, United States - Source
The New England journal of medicine. 2013, Vol 369, Num 14, pp 1317-1326, 10 p ; ref : 35 ref
- CODEN
- NEJMAG
- ISSN
- 0028-4793
- Scientific domain
- General medicine general surgery
- Publisher
- Massachusetts Medical Society, Waltham, MA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Diabète de type 2 Homme Hypoglycémiant Médecine Pronostic Saxagliptine Dipeptidyl-peptidase IV Endocrinopathie Enzyme Gliptine dérivé Hydrolases Inhibiteur de la dipeptidyl-peptidase IV Inhibiteur enzyme Maladie métabolique Peptidases
- Keyword (en)
- Type 2 diabetes Human Hypoglycemic agent Medicine Prognosis Saxagliptin Dipeptidyl-peptidase IV Endocrinopathy Enzyme Gliptine derivatives Hydrolases Dipeptidyl-peptidase IV inhibitor Enzyme inhibitor Metabolic diseases Peptidases
- Keyword (es)
- Diabetes de tipo 2 Hombre Hipoglicemiante Medicina Pronóstico Saxagliptina Dipeptidyl-peptidase IV Endocrinopatía Enzima Gliptina derivado Hydrolases Inbibidor Dipeptidyl-peptidase IV Inhibidor enzima Metabolismo patología Peptidases
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B21 Endocrinopathies / 002B21E Endocrine pancreas. Apud cells (diseases) / 002B21E01 Diabetes. Impaired glucose tolerance / 002B21E01A Etiopathogenesis. Screening. Investigations. Target tissue resistance
- Discipline
- Endocrinopathies Generalities in medical sciences
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27746083
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1056/NEJMoa1307684 
https://dx.doi.org/10.1056/NEJMoa1307684
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1307684\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:81:\"Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"369\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"1317\";s:8:\"\u0000*\u0000epage\";s:4:\"1326\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SCIRICA\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Benjamin M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:15:\"BHATT, Deepak L\";i:1;s:19:\"CAVENDER, Matthew A\";i:2;s:14:\"UDELL, Jacob A\";i:3;s:14:\"DESAI, Nihar R\";i:4;s:14:\"MOSENZON, Ofri\";i:5;s:17:\"MCGUIRE, Darren K\";i:6;s:13:\"RAY, Kausik K\";i:7;s:18:\"LEITER, Lawrence A\";i:8;s:11:\"RAZ, Itamar\";i:9;s:17:\"BRAUNWALD, Eugene\";i:10;s:16:\"STEG, P. Gabriel\";i:11;s:15:\"DAVIDSON, Jaime\";i:12;s:15:\"HIRSHBERG, Boaz\";i:13;s:12:\"OHMAN, Peter\";i:14;s:17:\"FREDERICH, Robert\";i:15;s:18:\"WIVIOTT, Stephen D\";i:16;s:17:\"HOFFMAN, Elaine B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:81:\"Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1307684\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:81:\"Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"369\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"1317\";s:8:\"\u0000*\u0000epage\";s:4:\"1326\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SCIRICA\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Benjamin M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:15:\"BHATT, Deepak L\";i:1;s:19:\"CAVENDER, Matthew A\";i:2;s:14:\"UDELL, Jacob A\";i:3;s:14:\"DESAI, Nihar R\";i:4;s:14:\"MOSENZON, Ofri\";i:5;s:17:\"MCGUIRE, Darren K\";i:6;s:13:\"RAY, Kausik K\";i:7;s:18:\"LEITER, Lawrence A\";i:8;s:11:\"RAZ, Itamar\";i:9;s:17:\"BRAUNWALD, Eugene\";i:10;s:16:\"STEG, P. Gabriel\";i:11;s:15:\"DAVIDSON, Jaime\";i:12;s:15:\"HIRSHBERG, Boaz\";i:13;s:12:\"OHMAN, Peter\";i:14;s:17:\"FREDERICH, Robert\";i:15;s:18:\"WIVIOTT, Stephen D\";i:16;s:17:\"HOFFMAN, Elaine B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:81:\"Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1307684\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1307684\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:81:\"Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"369\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"1317\";s:8:\"\u0000*\u0000epage\";s:4:\"1326\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SCIRICA\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Benjamin M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:15:\"BHATT, Deepak L\";i:1;s:19:\"CAVENDER, Matthew A\";i:2;s:14:\"UDELL, Jacob A\";i:3;s:14:\"DESAI, Nihar R\";i:4;s:14:\"MOSENZON, Ofri\";i:5;s:17:\"MCGUIRE, Darren K\";i:6;s:13:\"RAY, Kausik K\";i:7;s:18:\"LEITER, Lawrence A\";i:8;s:11:\"RAZ, Itamar\";i:9;s:17:\"BRAUNWALD, Eugene\";i:10;s:16:\"STEG, P. Gabriel\";i:11;s:15:\"DAVIDSON, Jaime\";i:12;s:15:\"HIRSHBERG, Boaz\";i:13;s:12:\"OHMAN, Peter\";i:14;s:17:\"FREDERICH, Robert\";i:15;s:18:\"WIVIOTT, Stephen D\";i:16;s:17:\"HOFFMAN, Elaine B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:81:\"Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1307684\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:81:\"Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"369\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"1317\";s:8:\"\u0000*\u0000epage\";s:4:\"1326\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SCIRICA\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Benjamin M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:15:\"BHATT, Deepak L\";i:1;s:19:\"CAVENDER, Matthew A\";i:2;s:14:\"UDELL, Jacob A\";i:3;s:14:\"DESAI, Nihar R\";i:4;s:14:\"MOSENZON, Ofri\";i:5;s:17:\"MCGUIRE, Darren K\";i:6;s:13:\"RAY, Kausik K\";i:7;s:18:\"LEITER, Lawrence A\";i:8;s:11:\"RAZ, Itamar\";i:9;s:17:\"BRAUNWALD, Eugene\";i:10;s:16:\"STEG, P. Gabriel\";i:11;s:15:\"DAVIDSON, Jaime\";i:12;s:15:\"HIRSHBERG, Boaz\";i:13;s:12:\"OHMAN, Peter\";i:14;s:17:\"FREDERICH, Robert\";i:15;s:18:\"WIVIOTT, Stephen D\";i:16;s:17:\"HOFFMAN, Elaine B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:81:\"Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1307684\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:81:\"Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"369\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"1317\";s:8:\"\u0000*\u0000epage\";s:4:\"1326\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SCIRICA\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Benjamin M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:15:\"BHATT, Deepak L\";i:1;s:19:\"CAVENDER, Matthew A\";i:2;s:14:\"UDELL, Jacob A\";i:3;s:14:\"DESAI, Nihar R\";i:4;s:14:\"MOSENZON, Ofri\";i:5;s:17:\"MCGUIRE, Darren K\";i:6;s:13:\"RAY, Kausik K\";i:7;s:18:\"LEITER, Lawrence A\";i:8;s:11:\"RAZ, Itamar\";i:9;s:17:\"BRAUNWALD, Eugene\";i:10;s:16:\"STEG, P. Gabriel\";i:11;s:15:\"DAVIDSON, Jaime\";i:12;s:15:\"HIRSHBERG, Boaz\";i:13;s:12:\"OHMAN, Peter\";i:14;s:17:\"FREDERICH, Robert\";i:15;s:18:\"WIVIOTT, Stephen D\";i:16;s:17:\"HOFFMAN, Elaine B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:81:\"Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
